Growth Metrics

Hyster-Yale (HY) EBIT (2016 - 2025)

Hyster-Yale (HY) has disclosed EBIT for 15 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT fell 89.73% year-over-year to $3.4 million, compared with a TTM value of $48.5 million through Sep 2025, down 81.43%, and an annual FY2025 reading of -$11.7 million, down 104.78% over the prior year.
  • EBIT was $3.4 million for Q3 2025 at Hyster-Yale, up from -$8.5 million in the prior quarter.
  • Across five years, EBIT topped out at $95.6 million in Q2 2024 and bottomed at -$107.0 million in Q4 2021.
  • Average EBIT over 5 years is $14.6 million, with a median of $19.8 million recorded in 2022.
  • The sharpest move saw EBIT crashed 881.02% in 2021, then soared 474.52% in 2023.
  • Year by year, EBIT stood at -$107.0 million in 2021, then soared by 118.5% to $19.8 million in 2022, then surged by 145.96% to $48.7 million in 2023, then crashed by 33.68% to $32.3 million in 2024, then tumbled by 89.47% to $3.4 million in 2025.
  • Business Quant data shows EBIT for HY at $3.4 million in Q3 2025, -$8.5 million in Q2 2025, and $21.3 million in Q1 2025.